St Pharm Co (XKRX:237690) Debt-to-Asset : 0.16 (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is St Pharm Co Debt-to-Asset?

St Pharm Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩73,375 Mil. St Pharm Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩44,767 Mil. St Pharm Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩721,876 Mil. St Pharm Co's debt to asset for the quarter that ended in Dec. 2024 was 0.16.

St Pharm Co Debt-to-Asset Historical Data

The historical data trend for St Pharm Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Pharm Co Debt-to-Asset Chart

St Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.29

0.22

0.24

0.28

0.16

St Pharm Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.28	0.27	0.24	0.18	0.16

Competitive Comparison of St Pharm Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

St Pharm Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where St Pharm Co's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

St Pharm Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

St Pharm Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(73375.061	+	44766.815)	/	721875.71
	=	0.16

St Pharm Co's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(73375.061	+	44766.815)	/	721875.71
	=	0.16

St Pharm Co (XKRX:237690) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

St Pharm Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of St Pharm Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

St Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » St Pharm Co Ltd (XKRX:237690) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43

Website

http://www.stpharm.co.kr

St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.

St Pharm Co Headlines

No Headlines